Top Story

Growth hormone reduces osteoporotic fracture risk in older women

August 28, 2015

Older women with osteoporosis treated with growth hormone showed a reduced risk for fracture and improved bone density that continued for years after stopping treatment, according to research in The Journal of Clinical Endocrinology & Metabolism.

In a randomized, double blind, placebo-controlled trial, researchers found that the women assigned GH injections for 36 months reduced their rate of osteoporotic fracture by 50% compared with women who received a placebo injection for 18 months.

Peter Humaidan In the Journals

Pregnancy success rate with daily, low-dose hCG injection similar to vaginal hormonal gel

August 27, 2015
A daily subcutaneous injection of human chorionic gonadotropin for 2 weeks after an embryo transfer resulted in as many successful pregnancies for women as those who…
In the Journals

Postmenopausal women do not benefit from higher dosing of Vitamin D

August 3, 2015
Musculoskeletal health of postmenopausal women with vitamin D deficiencies did not improve with high-dose cholecalciferol, according to recently published data in JAMA
Jacques Baillargeon, PhD In the Journals

Testosterone therapy not linked to VTE

July 22, 2015
Filling a testosterone prescription was not associated with increased risk for venous thromboembolism in middle-aged and older men, according to a new case-control…
More News Headlines »
In the Journals
Johanna Olson

Hormone levels of transgender youth consistent with assigned sex

July 21, 2015
Transgender teens and young adults have sex hormone levels consistent with their assigned gender at birth, according to…
More »
Meeting News Coverage Video
4131397887001 th

Vlog: Global endocrinology community gathers for ICE/ENDO 2014

June 21, 2014
Ronald Tamler, MD, PhD, MBA, clinical director of the Mount Sinai Diabetes Center and a member of the Endocrine Today
More »
Current Issues
View the Current Issues
morganatic-roan